In European Pharmaceutical Review, Helen Farr of Taylor Wessing explores the potential legal implications for life sciences companies banning people from using the app while at work.
2 November 2020
The NHS COVID-19 App was introduced in the UK on 24 September. Many welcome its arrival as another step to contain the spread of COVID-19, while others are concerned about using the app for data and privacy reasons.
In European Pharmaceutical Review, Helen Farr of Taylor Wessing explores the potential legal implications for life sciences companies banning people from using the app while at work.